<?xml version='1.0' encoding='UTF-8'?><!DOCTYPE collection SYSTEM 'BioC.dtd'>
<collection>
  <source>SourceData</source>
  <date>00000000</date>
  <key>sourcedata.key</key>
  <document>
    <id>4988506 Figure_3-B</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-B</infon>
    <infon key="sourcedata_figure_dir">Figure_3-B</infon>
    <passage>
      <offset>0</offset>
      <text>(B) Irg1mRNA expression profile in BMDMs stimulated with LPS, normalized to Hprt (AU, arbitrary units). Error bars represent 95 % confidence interval, n = 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_3-C</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-C</infon>
    <infon key="sourcedata_figure_dir">Figure_3-C</infon>
    <passage>
      <offset>0</offset>
      <text>(C) Irg1 mRNA stability assay. BMDMs were stimulated for 3 h (left panel) or 9 h (right panel) with LPS and transcription was stopped by actinomycin D (ActD) followed by measurements of remaining mRNA 30 and 60 min after the transcription blockage. Irg1 mRNA is stable (half-life&gt;180 min) after 3 h and 9 h of LPS stimulation in both WT and TTP-deficient BMDMs.</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_3-D</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-D</infon>
    <infon key="sourcedata_figure_dir">Figure_3-D</infon>
    <passage>
      <offset>0</offset>
      <text>(D) Expression profile of intron 3 (I3) (left panel) and the TTP binding site- containing intron 4 (I4, right panel) of Irg1, normalized to Hprt. Error bars represent 95 % confidence interval, n = 3 biological replicates.</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_3-E</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-E</infon>
    <infon key="sourcedata_figure_dir">Figure_3-E</infon>
    <passage>
      <offset>0</offset>
      <text>(E) Irg1 read coverage in RNA-Seq experiments for WT and &#916;M BMDMs BMDMs. Irg1 gene (ENSMUSG00000022126) has a single annotated transcript (ENSMUST00000022722),</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_3-F</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-F</infon>
    <infon key="sourcedata_figure_dir">Figure_3-F</infon>
    <passage>
      <offset>0</offset>
      <text>(F) TTP binds to spliced-out intron 4. Data depict RNA-IP experiments showing that TTP binds to intron 4 (I4) but not to the pre-mRNA containing exon 4 and intron 4 (E4-I4) (upper panel). PCR design for detection of cDNA corresponding to intron 3, intron 4, exon 4/intron 4 is shown in lower panel. Binding to Tnf mRNA was used as a positive control. Data are presented in arbitrary units (AU) as 225-Ct.</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_3-G</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 3-G</infon>
    <infon key="sourcedata_figure_dir">Figure_3-G</infon>
    <passage>
      <offset>0</offset>
      <text>(G) Western blot showing stable amounts of nuclear TTP during LPS stimulation for indicated times. Tubulin and histone H3 were used as controls for successful separation of cytoplasmic (tubulin) from nuclear (histone H3) fractions, respectively.</text>
    </passage>
  </document>
  <document>
    <id>4988506 Figure_4-H</id>
    <infon key="sourcedata_document">1817</infon>
    <infon key="doi">10.15252/msb.20156628</infon>
    <infon key="pmc_id">4988506</infon>
    <infon key="figure">Figure 4-H</infon>
    <infon key="sourcedata_figure_dir">Figure_4-H</infon>
    <passage>
      <offset>0</offset>
      <text>(H) Sequential native RNA-IP from WT and &#916;M BMDMs. Simultaneous binding of TTP and HuR to the same RNA molecule was tested with IP using anti-TTP antibodies (first IP) followed by elution with specific peptide and consecutive IP with anti-HuR antibodies (second IP). Second IP performed with anti-tubulin antibodies serves as a control for the specificity of second IP reaction. Sample with &#916;M BMDMs was used as a control for the specificity of the TTP antibody.</text>
    </passage>
  </document>
</collection>
